A five - year review of gestational trophoblastic diseases in Port Harcourt, Nigeria.
Article Sidebar
Main Article Content
Abstract
Background: Gestational Trophoblastic Diseases (GTD) are a spectrum of inter-related but histologically distinct tumours originating from the placenta with good prognosis when diagnosed early.
Aim: To determine the prevalence, clinical presentations, management of gestational trophoblastic disease at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.
Methods: A retrospective analysis of women treated for gestational trophoblastic disease from 1st January 2008 to 31stDecember 2012. The information from patients records: age, occupation, educational level, husband's occupation, parity, presenting symptoms, uterine size, mode of treatment and management options were collated and analysed. The Chi-square test was used to compare categorical variables with a p value of ≤ 0.05 as significant.
Results: A total of 38 cases of GTD were treated with a prevalence of 2.3 per 1,000 deliveries. The mean age and parity were 31 ± 6.3 years and 2 ± 1.6 respectively. Maternal age less than 35 years and low socioeconomic status were significantly associated with GTD (p=0.0000). The mean gestational age at presentation was 16.24 ± 5.4 weeks. The commonest clinical presentation was amenorrhoea in 100% of patients. Twenty-five(65.8%) cases of hydatidiform mole and 13(34.2%) cases of choriocarcinoma were observed. Twenty-two (57.9%) patients had suction evacuation only for hydatidiform mole, 3(7.9.%) had suction evacuation and cytotoxic therapy for hydatidiform mole and subsequent persistent trophoblastic disease while 8(21.1%) had chemotherapy for choriocarcinoma. Five patients with advanced choriocarcinoma did not receive definitive treatment before demise. Twenty (52.6%)defaulted in their follow up schedule.
Conclusion: There is high prevalence of GTD in Port Harcourt with high mortality among patients with malignancy. Most of the patients defaulted in their follow up; thus there is a need for education and sensitization of the populace on GTD, as well as proper counseling of patients treated on the benefits of follow up visits
Downloads
Article Details
The journal grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
References
1 Aghajanian P. Gestational trophoblastic diseases. In: DeCherney AH, Nathan L, Goodwin TM, Laufer N, eds, Current obstetrics & gynaecologic diagnosis & the treatment, 10 edition. New York: McGraw Hill, 2007: 885-886.
2 Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract, 5thed. New York: Springer Verlag, 2002; 1192-1224.
3 Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994; 39: 155-162.
4 Osamor JO, OluwasolaAO, Adewole IF. A clinico-pathologic study of complete and partial hydatidiform moles in a Nigerian population. J Obstet Gynaecol 2002; 22: 423-425.
5 Akosa AB, Ampadu FO, Gyasi RK. A review of complete hydatidiform moles in Ghana. Ghana Med J 2001; 35:85-89.
6 Chechia A, Koubaa A, Makhlouf T, AnisB, Terras K, Hamouda B, Mezni F. [Molar pregnancy retrospective study of 60 cases in Tunisia]. Tunis Med 2001; 79: 441-446
7 Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med 1998; 43: 60-68.
8 Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004; 20: 63-68.
9 Parazzini F, Mangili G, LaVecchia C, Negri E, Bocciolone L, Fasoli M. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles. Obstet Gynecol 1991; 78: 1039-1045.
10 Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG 2002; 109: 99-102.
11 Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med 2008; 53: 481-486.
12 Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG 2003; 110: 22-26.
13 Lazarus E, Hulka C, Siewert B, Levine D. Sonographic appearance of early complete molar pregnancies. J Ultrasound Med 1999; 18: 589-594.
14 Mosher R, Goldstein DP, Berkowitz R,Bernstein M, Genest DR. Complete hydatidifor m mole. Comparison of
clinicopathologic features, current and past. J Reprod Med 1998; 43: 21-27.
15 Gillespie AM, Lidbury EA, Tidy JA, Hancock BW. The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation. Int J Gynecol Cancer 2004; 14: 366-369.
16 Sasaki S. Clinical presentation and management of molar pregnancy. Best Pract Res Clin Obstet Gynaecol 2003; 17: 885-892.
17 Benson CB, Genest DR, Bernstein MR, SotoWright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000; 16:188-191.
18 Olusanya O, Okpere E, Ezimokhai M. The importance of social class in voluntary fertility control. West Afr J Med 1985;4:205-212.
19 Mbamara SU, Obiechina NJ, Eleje GU, Akabuike CJ, Umeononihu OS. Gestational trophoblastic disease in a tertiary hospital in Nnewi, southeast Nigeria. Niger Med J 2009; 50: 87-89.
20 Bugti QA, Baloch N, Baloch MA. Gestational trophoblastic disease in Quetta. Pak J Med Res 2005; 44: 92-95.
21 Anuma ON, Umeora OU, Obuna JA, Agwu UM. Profiling gestational trophoblastic disease in a tertiary hospital in South-East Nigeria. Trop J Obstet Gynaecol 2009; 26: 157-164.
22 Obiechina NJ, Udigwe GO, Obi RA. Molar pregnancy a ten-year review at Onitsha Nigeria. Journal of Medical Investigation and Practice (JOMIP) 2001; 13: 26-31.
23 Thirumagal B., Sinha D,Raghavan R, Bhatti N. Gestational trophoblastic neoplasm: are we compliant with the standard? J Obstet Gynaecol 2009; 29: 434-436.
24 Gerulath AH, Ehlen TG, Bessette P, Jolicoeur L, Savoie R; Society of Obstetricians and Gynaecologists of Canada; Gynaecologic Oncologists of Canada; Society of Canadian Colposcopist. Gestational trophoblastic disease. J Obstet Gynaecol Can 2002;24:434-446.
25 Hou JL, Wan XR, Xiang Y, Qi QW, Yang XY. Changes of clinical features in hydatidiform
mole: analysis of 113 cases. J Reprod Med 2008; 53: 629-633.
26 Synman LC. Gestational trophoblastic disease: an overview. South Afr J Gynaecol Oncol 2009; 1: 32-37.
27 Osubor KM, Fatusi AO, Chiwuzie JC.Maternal health -seeking behavior and associated factors in rural Nigerian
community. Matern Child Health J 2006; 10:159-169.
28 Kazauru MR, Kombe D, Yuma S, Mtiro H, Mlawa G.Health seeking behaviour amongst patients attending Ocean Road cancer institute, Tanzania. East Afr J Public Health 2007;4: 19-22.
29 Mourali M, Fkih C, Essoussi-Chikhaoui J,Ben Haj Hassine A,Binous N, Ben Zinab N, Boussen H.Gestational tropholastic disease in Tunisia. Tunis Med 2008; 86: 665-669
30 Ocheke AN, Musa J, Uamai AO. Hydatiform mole in Jos, Nigeria. Niger Med J 2011; 52:223-226.
31 Khaskheli M, Khushk IA, Baloch S, Shah H. Gestational trophoblastic disease: experience at a tertiary care hospital of Sindh. J Coll Physicians Surg Pak 2007; 17: 81-83.
32 Igwegbe AO, Eleje GU. Hydatidiform mole: a review of management outcome in a tertiary hospital in South East Nigeria. Ann Med Health Sci Res 2013; 3:210-214.
33 Deng L, Zhang J, Wu T, Lawrie TA. Combination chemotherapy for primary treatment of high risk gestationaltrophoblastic tumours. Cochrane Database Syst Rev 2013 . 1 : CD005196 doi 10.1002/14651858 . ( Last a c c e s s e d th11 December 2015.)